Skip to main content
Michael Satlin, MD, Infectious Disease, New York, NY, New York-Presbyterian Hospital

MichaelJosephSatlinMD

Infectious Disease • New York, NY

Instructor, Medicine, Weill Cornell Medical College

Request Appointment

Overview of Dr. Satlin

Dr. Michael Satlin is an infectious disease specialist in New York, NY and is affiliated with New York-Presbyterian Hospital. He received his medical degree from University of Virginia School of Medicine and has been in practice 12 years. Dr. Satlin accepts several types of health insurance, listed below. He is one of 140 doctors at New York-Presbyterian Hospital who specialize in Infectious Disease. He has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 2008 - 2011
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2005 - 2008
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Journal Articles

  • Incidence, Significance, and Persistence of Human Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients  
    Catherine B Small, Rosemary Soave, Dana Zappetti, Michael J Satlin, Emily M Eichenberger, Tsiporah Shore, Nature
  • Gut Microbiota Dysbiosis and Diarrhea in Kidney Transplant Recipients  
    Eric Pamer, Manikkam Suthanthiran, Ying Taur, Michael J Satlin, Darshana Dadhania, John Richard Lee, Carl Crawford, Michelle Lubetzky, American journal of transplantation

Abstracts/Posters

  • Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive Chemotherapy
    Michael Satlin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Authored Content

  • Polymyxin B and Fosfomycin Thwart KPC-Producing Klebsiella Pneumoniae in the Hollow Fibre Infection ModelFebruary 2018
  • Polymyxin B and Fosfomycin Thwart KPC-Producing Klebsiella Pneumoniae in the Hollow Fibre Infection ModelFebruary 2018

Press Mentions

  • Shionogi to Present in Vitro and Real-World Data at IDWeek 2021 Demonstrating Activity of FETCROJA® (Cefiderocol) Against Gram-Negative Pathogens
    Shionogi to Present in Vitro and Real-World Data at IDWeek 2021 Demonstrating Activity of FETCROJA® (Cefiderocol) Against Gram-Negative PathogensSeptember 29th, 2021
  • $750K Awarded for Intercampus Research
    $750K Awarded for Intercampus ResearchMarch 2nd, 2021
  • You’re Infected with the Coronavirus. But How Infected?
    You’re Infected with the Coronavirus. But How Infected?December 29th, 2020
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Cofinity PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    Great West PPO
    HealthAmerica HealthAssurance PPO
    Humana ChoiceCare Network PPO
    Medical Mutual of Ohio SuperMed Plus
    Medical Mutual of Ohio SuperMed POS
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Michael Satlin, Dr. Michael Satlin, MD, Dr. M Satlin, Dr. Michael Joseph Satlin